Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Divestments (2017 - 2019)

Healthstream (HSTM) reported Divestments of $35000.0 for Q4 2019, down 99.92% year-over-year from $44.2 million in Q4 2018, and up 118.72% on a QoQ basis from -$187000.0 in Q3 2019.

Healthstream (HSTM) has 3 years of Divestments data on file, last reported at $35000.0 in Q4 2019.

  • Quarterly Divestments fell 99.92% year-over-year to $35000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $44.0 million (changed 0.08% YoY) and the FY2019 annual result came in at $6.1 million, down 86.22% from the prior year.
  • Divestments grew to $35000.0 in Q4 2019 per HSTM's latest filing, from -$187000.0 in the prior quarter.
  • Across five years, Divestments topped out at $44.2 million in Q4 2018 and bottomed at -$839000.0 in Q2 2017.
  • The 3-year median for Divestments is -$151000.0 (2018), against an average of $4.1 million.
  • The widest annual swing landed in 2018, when Divestments soared 8218.38%; it then plunged 18800.0% in 2019.
  • Tracing HSTM's Divestments over 3 years: stood at -$544000.0 in 2017, then soared by 8218.38% to $44.2 million in 2018, then sank by 99.92% to $35000.0 in 2019.
  • Per Business Quant, the three latest HSTM Divestments figures stand at $35000.0 (Q4 2019), -$187000.0 (Q3 2019), and $44.2 million (Q4 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 810.91 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Healthstream 752.32 Mn 685.82 Mn 68.24 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 35,000.00
Sep 30, 2019 -187,000.00
Dec 31, 2018 44.16 Mn
Sep 30, 2018 1,000.00
Jun 30, 2018 -1,000.00
Mar 31, 2018 -115,000.00
Dec 31, 2017 -544,000.00
Sep 30, 2017 -741,000.00
Jun 30, 2017 -839,000.00
Mar 31, 2017 -637,000.00